IT1110450B - Estratto di cellule batteriche processo di sua preparazione preparato antitumorale e preparato coadiuvante contenente lo stesso - Google Patents

Estratto di cellule batteriche processo di sua preparazione preparato antitumorale e preparato coadiuvante contenente lo stesso

Info

Publication number
IT1110450B
IT1110450B IT20841/79A IT2084179A IT1110450B IT 1110450 B IT1110450 B IT 1110450B IT 20841/79 A IT20841/79 A IT 20841/79A IT 2084179 A IT2084179 A IT 2084179A IT 1110450 B IT1110450 B IT 1110450B
Authority
IT
Italy
Prior art keywords
preparation
same
bacterial cell
cell extract
tumor
Prior art date
Application number
IT20841/79A
Other languages
English (en)
Italian (it)
Other versions
IT7920841A0 (it
Original Assignee
Mitsui Toatsu Chemicals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsui Toatsu Chemicals filed Critical Mitsui Toatsu Chemicals
Publication of IT7920841A0 publication Critical patent/IT7920841A0/it
Application granted granted Critical
Publication of IT1110450B publication Critical patent/IT1110450B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55588—Adjuvants of undefined constitution
    • A61K2039/55594—Adjuvants of undefined constitution from bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IT20841/79A 1978-03-10 1979-03-08 Estratto di cellule batteriche processo di sua preparazione preparato antitumorale e preparato coadiuvante contenente lo stesso IT1110450B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2651978A JPS54140710A (en) 1978-03-10 1978-03-10 Anti-tumor substance and its preparation

Publications (2)

Publication Number Publication Date
IT7920841A0 IT7920841A0 (it) 1979-03-08
IT1110450B true IT1110450B (it) 1985-12-23

Family

ID=12195716

Family Applications (1)

Application Number Title Priority Date Filing Date
IT20841/79A IT1110450B (it) 1978-03-10 1979-03-08 Estratto di cellule batteriche processo di sua preparazione preparato antitumorale e preparato coadiuvante contenente lo stesso

Country Status (7)

Country Link
US (1) US4726947A (enExample)
JP (1) JPS54140710A (enExample)
CA (1) CA1146467A (enExample)
DE (2) DE2908241C2 (enExample)
FR (1) FR2419071A1 (enExample)
GB (1) GB2015876B (enExample)
IT (1) IT1110450B (enExample)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5632489A (en) * 1979-08-28 1981-04-01 Mitsui Toatsu Chem Inc Antitumor active substance and its pharmaceutical
JPS5632490A (en) * 1979-08-28 1981-04-01 Mitsui Toatsu Chem Inc Antitumor active substance and its pharmaceutical
FR2466247A1 (fr) * 1979-10-03 1981-04-10 Decroix Guy Preparation immuno-stimulante et application
DE3048699C2 (de) * 1980-12-23 1985-03-28 Chisato Tokio/Tokyo Maruyama Immuntherapeutisches Mittel gegen Tumore, enthaltend als wirksame Komponente ein Lipopolysaccharid
KR940005589B1 (ko) * 1986-04-02 1994-06-21 다이닛뽄세이야꾸 가부시끼가이샤 핵산 또는 엔도톡신의 제거제 및 제거방법
US5527770A (en) * 1993-08-06 1996-06-18 International Gene Group, Inc. Immunotherapeutic agent derived from bacteria
US6090385A (en) * 1993-12-10 2000-07-18 Maes; Hubert Method of treating cancer
DE4422859C2 (de) * 1994-06-30 2000-10-05 Laves Arzneimittel Gmbh Wäßrige Zellextrakte aus Mykobacterien
US5759992A (en) * 1994-08-31 1998-06-02 David Platt Immunotherapeutic agent derived from bacteria and method for its manufacture
EP0710484A3 (en) * 1994-10-07 1996-10-23 Univ Illinois Mixture of alpha-D-glucopyranosyl- (1-6) -alpha-D glucopyranose as an anti-tumor agent
EP0796280B1 (en) 1994-12-28 2003-03-26 University Of Kentucky Murine monoclonal anti-idiotype antibody 3h1
WO1996021672A1 (en) * 1995-01-09 1996-07-18 International Gene Group, Inc. Immunotherapeutic agent derived from bacteria
US6949244B1 (en) * 1995-12-20 2005-09-27 The Board Of Trustees Of The University Of Kentucky Murine monoclonal anti-idiotype antibody 11D10 and methods of use thereof
US20020041872A1 (en) * 1996-04-12 2002-04-11 Malaya Chatterjee Methods of delaying development of CEA-associated tumors using anti-idiotype antibody 3H1
US6235280B1 (en) 1996-04-12 2001-05-22 Malaya Chatterjee Methods of delaying development of CEA-associated tumors using anti-idiotype antibody 3H1
US6468782B1 (en) 1996-12-05 2002-10-22 Quadrant Healthcare (Uk) Limited Methods of preserving prokaryotic cells and compositions obtained thereby
AU727781B2 (en) * 1997-04-02 2000-12-21 Bioniche Life Sciences Inc. Use of bacterial cell wall extract for preventing, treating, or eliminating a protozoal or parasitic disease
CN1292073C (zh) * 1997-06-03 2006-12-27 森庸厚 天然抗肿瘤性或抗病毒性物质及其用途
US6274143B1 (en) 1997-06-13 2001-08-14 Malaya Chatterjee Methods of delaying development of HMFG-associated tumors using anti-idiotype antibody 11D10
US20020098190A1 (en) * 1997-06-13 2002-07-25 Malaya Chatterjee Compositions and methods for treating tumors bearing HMFG and CEA antigens
US20020122807A1 (en) * 1998-07-07 2002-09-05 Dan Michael D. Antigen binding fragments, designated 4B5, that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers
KR100533576B1 (ko) 1997-08-05 2005-12-05 바이오니취 라이프 사이언시즈 인코포레이티드 세포증식 및 세포사멸 조절용 조성물 및 방법
US6355244B1 (en) 1997-11-17 2002-03-12 University Of Kentucky Research Foundation Methods and compositions for the treatment of psoriasis
US20020068068A1 (en) * 1999-02-02 2002-06-06 Mahan Michael J. Method of creating antibodies and compositions used for same
US7026155B2 (en) 1999-02-02 2006-04-11 Regents Of The University Of California Method of reducing bacterial proliferation
EP1867718B1 (en) * 1999-12-13 2010-01-20 Bioniche Life Sciences Inc. Therapeutically useful synthetic oligonucleotides
CA2395493C (en) * 1999-12-28 2010-06-22 Bioniche Life Sciences Inc. Hyaluronic acid in the treatment of cancer
JP4859341B2 (ja) * 2001-07-19 2012-01-25 昭 林 ヒト免疫療法
US7153265B2 (en) * 2002-04-22 2006-12-26 Medtronic Minimed, Inc. Anti-inflammatory biosensor for reduced biofouling and enhanced sensor performance
US20040265337A1 (en) * 2002-08-21 2004-12-30 Zsebo Krisztina M. Method of generating an immune response and compositions used for same
WO2005082389A1 (ja) * 2004-02-27 2005-09-09 Fuji Oil Company, Limited 癌転移抑制組成物
CN102441162B (zh) * 2010-10-04 2018-07-24 免疫产品美国股份有限公司 结核病的治疗和预防
EP2679232A1 (en) * 2012-06-29 2014-01-01 Lysando Aktiengesellschaft Composition for use in Mycobacteria vaccination
EP2679677A1 (en) * 2012-06-29 2014-01-01 Lysando Aktiengesellschaft Composition for use in Mycobacteria therapy
WO2014001571A1 (en) * 2012-06-29 2014-01-03 Lysando Ag Composition for use in mycobacteria diagnosis
EP3106539A1 (en) * 2014-02-12 2016-12-21 Hyeong Gon Lee Thin film cluster production system, thin film cluster, thin film, uv protector, and cosmetics
CN114621946B (zh) * 2022-04-07 2023-07-04 施可丰化工股份有限公司 一种防治大豆根腐病的生防菌剂及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3399263A (en) * 1965-04-12 1968-08-27 American Cyanamid Co Stable adjuvant emulsion compositions comprising the hydrated reaction products of a methallic cation and a fatty acid
GB1188519A (en) * 1966-10-27 1970-04-15 Wellcome Found Method for the Purification of Lipopolysaccharides
US3790665A (en) * 1968-02-23 1974-02-05 Haver Lockhart Labor Inc Injectable adjuvant,method of preparing same and compositions including such adjuvant
GB1426042A (en) * 1971-11-26 1976-02-25 Anvar water-soluble immunological adjuvants
FR2189021A1 (en) * 1972-06-20 1974-01-25 Anvar Non-arthrogenic immunological adjuvants - obtained by extraction of lipid-free mycobacterial residues
US4001395A (en) * 1972-06-20 1977-01-04 Agence Nationale De Valorisation De La Recherche (Anvar) Hydrosoluble extracts of mycobacteria
NL7308450A (enExample) * 1972-06-20 1973-12-27
US3976544A (en) * 1973-06-19 1976-08-24 The Agence Nationale De Valorisation De Le Recherche Water-soluble immunological adjuvants, in particular for vaccines, obtained from mycobacteria and related microorganisms and process for their extraction
SU552744A1 (ru) * 1975-12-25 1977-11-05 Московский Научно-Исследовательский Институт Вакцин И Сывороток Им. И.И. Мечникова Министерства Здравоохранения Ссср Способ получени растворимого коклюшного иммуноадъюванта

Also Published As

Publication number Publication date
GB2015876B (en) 1982-08-18
US4726947A (en) 1988-02-23
DE2954387C2 (de) 1986-10-09
CA1146467A (en) 1983-05-17
JPS54140710A (en) 1979-11-01
GB2015876A (en) 1979-09-19
IT7920841A0 (it) 1979-03-08
JPS6241214B2 (enExample) 1987-09-02
DE2908241C2 (de) 1985-10-31
DE2908241A1 (de) 1979-09-13
FR2419071A1 (fr) 1979-10-05
FR2419071B1 (enExample) 1983-02-11

Similar Documents

Publication Publication Date Title
IT1110450B (it) Estratto di cellule batteriche processo di sua preparazione preparato antitumorale e preparato coadiuvante contenente lo stesso
DE3063736D1 (en) Improvements in or relating to immunological preparations
KR880006768A (ko) 진공핀셋
GB2038858B (en) Bis-(silylethyl) - oligosulphides and preparation thereof
DE3066507D1 (de) Anti-acne composition comprising diisopropyl sebacate
EP0062079A4 (en) THIN SILICONE FILM AND METHOD FOR THE PRODUCTION THEREOF.
IT7967299A0 (it) Pirimidoni e procedimento per laloro preparazione
AU532350B2 (en) Improvements in or relating to polycarbonates
DK251081A (da) Insectide praeparater
IT1133430B (it) Dispositivo per la lavorazione di superfici
IT1128157B (it) Procedimento per la preparazione di solfenammidi
NL7904771A (nl) Anti-tumor-preparaten.
ATA645979A (de) Episkop oder auflicht-direktbetrachter
JPS54128791A (en) Ion sensor using semiconductor field effect
IT8319542A0 (it) Perfezionamenti in e relativi adispositivi di analisi di colori.
AU5038079A (en) Laboratory minidigesters
IT1121519B (it) Processo per la preparazione di benzina
IT1129736B (it) Plasmide puc1 e processo per la sua preparazione
IT1142141B (it) Procedimento e substrato di fermentazione
IT1118412B (it) Procedimento per l analisi di immagini in movimento
IT1122242B (it) Procedimento per la preparazione di confetture
IT1129737B (it) Plasmide puc3 e processo per la sua preparazione
IT1122311B (it) Procedimento per la preparazione di triciclazolo
IT1151407B (it) Processo di preparazione di beta-cloroalanina
IT7968046A0 (it) Proteina purificata cancro associata e procedimento per la sua preparazione